NCT00286013已完成2 期
Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 8
- 主要终点
- Feasibility
研究概览
简要总结
The aim of the study is to evaluate the feasibility defined as overall tolerance and toxicity as well as relative dose-intensity and cumulative dose delivered, of an association ofgemcitabine, oxaliplatin and radiotherapy in patients with locally advanced and unresectable, but non-metastatic pancreatic adenocarcinoma or cholangiocarcinoma
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically proven and unresectable adenocarcinoma of the pancreas or cholangiocarcinoma with no evidence of metastatic disease
- •WHO performance status of 0 or 1
- •Complete recovrey from surgery in case an enteric and/or biliary tract by-pass operation has been performed
- •Maximum delay after surgery: 8 weeks
- •No previous or co-existent malignant disease except non melanoma skin cancers and adequately treated cervic carcinoma in situ
- •Adequate bon marrow reserve
- •No previous chemotherapy or radiotherapy
- •Expected survival > 6 months
排除标准
- •Active infection
- •Metastatic disease
- •Inadequate liver function after derivative surgery
- •Inadequate renal function
- •Pregnancy, breast feeding
- •Use of any other investigational agent in the month before enrollment
- •Patients with grade 2 or more neuropathy
结局指标
主要结局
Feasibility
Tolerance
次要结局
未报告次要终点
研究者
研究点 (8)
Loading locations...
相似试验
已完成
1 期
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast CancerBreast CancerNCT00724386University of Chicago26
进行中（未招募）
1 期
Feasibility of radiotherapy and concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinomaPancreatic cancer or distal cholangiocarcinomaEUCTR2004-001126-24-BEniversity Hospital Ghent30
尚未招募
2 期
Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in ChildrenRhabdomyosarcoma, ChildNCT05708391Xinhua Hospital, Shanghai Jiao Tong University School of Medicine53
招募中
不适用
Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung CancerSmall Cell Lung CarcinomaNCT06529081Copernicus Memorial Hospital165
Unknown
1 期
Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in ChildrenChildhood RhabdomyosarcomaNCT03868852Xinhua Hospital, Shanghai Jiao Tong University School of Medicine48